Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen

被引:71
作者
Gu, ML
Leppla, SH
Klinman, DM
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Sect Retroviral Immunol, Bethesda, MD 20014 USA
[2] NIDR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA
关键词
DNA vaccine; anthrax; toxin;
D O I
10.1016/S0264-410X(98)00210-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A DNA vaccine encoding the immunogenic and biologically active portion of anthrax protective antigen (PA) was constructed. Spleen cells from BALB/c mice immunized intramuscularly with this vaccine were stimulated to secrete IFN gamma and IL-4 when exposed to PA in vitro. Immunized mice also mounted a humoral immune response dominated by IgG1 anti-PA antibody production, the subclass previously shown to confer protection against anthrax toxin. A 1:100 dilution of serum from these animals protected cells in vitro against cytotoxic concentrations of PA. Moreover, 7/8 mice immunized three times with the PA DNA vaccine were protected against lethal challenge with a combination of anthrax protective antigen plus lethal factor. Published by Elsevier Science Ltd.
引用
收藏
页码:340 / 344
页数:5
相关论文
共 27 条
  • [1] FIELD-EVALUATION OF A HUMAN ANTHRAX VACCINE
    BRACHMAN, PS
    FEKETY, FR
    GOLD, H
    WERRIN, M
    INGRAHAM, NR
    PLOTKIN, SA
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1962, 52 (04): : 632 - +
  • [2] BACILLUS-ANTHRACIS PROTECTIVE ANTIGEN, EXPRESSED IN SALMONELLA-TYPHIMURIUM SL-3261, AFFORDS PROTECTION AGAINST ANTHRAX SPORE CHALLENGE
    COULSON, NM
    FULOP, M
    TITBALL, RW
    [J]. VACCINE, 1994, 12 (15) : 1395 - 1401
  • [3] IMMUNOELECTROPHORETIC ANALYSIS, TOXICITY, AND KINETICS OF INVITRO PRODUCTION OF THE PROTECTIVE ANTIGEN AND LETHAL FACTOR COMPONENTS OF BACILLUS-ANTHRACIS TOXIN
    EZZELL, JW
    IVINS, BE
    LEPPLA, SH
    [J]. INFECTION AND IMMUNITY, 1984, 45 (03) : 761 - 767
  • [4] PROTEOLYTIC ACTIVATION OF BACTERIAL TOXINS BY EUKARYOTIC CELLS IS PERFORMED BY FURIN AND BY ADDITIONAL CELLULAR PROTEASES
    GORDON, VM
    KLIMPEL, KR
    ARORA, N
    HENDERSON, MA
    LEPPLA, SH
    [J]. INFECTION AND IMMUNITY, 1995, 63 (01) : 82 - 87
  • [5] Experimental anthrax vaccines: Efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs
    Ivins, B
    Fellows, P
    Pitt, L
    Estep, J
    Farchaus, J
    Friedlander, A
    Gibbs, P
    [J]. VACCINE, 1995, 13 (18) : 1779 - 1784
  • [6] IMMUNIZATION AGAINST ANTHRAX WITH BACILLUS-ANTHRACIS PROTECTIVE ANTIGEN COMBINED WITH ADJUVANTS
    IVINS, BE
    WELKOS, SL
    LITTLE, SF
    CRUMRINE, MH
    NELSON, GO
    [J]. INFECTION AND IMMUNITY, 1992, 60 (02) : 662 - 668
  • [7] ANTHRAX TOXIN LETHAL FACTOR CONTAINS A ZINC METALLOPROTEASE CONSENSUS SEQUENCE WHICH IS REQUIRED FOR LETHAL TOXIN ACTIVITY
    KLIMPEL, KR
    ARORA, N
    LEPPLA, SH
    [J]. MOLECULAR MICROBIOLOGY, 1994, 13 (06) : 1093 - 1100
  • [8] KLINMAN DM, 1994, CURRENT PROTOCOLS IM, P7
  • [9] ANTHRAX TOXIN EDEMA FACTOR - A BACTERIAL ADENYLATE-CYCLASE THAT INCREASES CYCLIC-AMP CONCENTRATIONS IN EUKARYOTIC CELLS
    LEPPLA, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10): : 3162 - 3166
  • [10] LEPPLA SH, 1995, TOXINS VIRULENCE FAC, P543